ORIGINAL RESEARCH
Published on 23 Sep 2022
A novel germline HAVCR2 (TIM-3) compound heterozygous mutation is related to hemophagocytic lymphohistiocytic syndrome in EBV-positive peripheral T-cell lymphoma (NOS) with down-regulated TIM-3 signaling

doi 10.3389/fonc.2022.870676
- 1,602 views
- 3 citations